{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:59:50Z","timestamp":1787507990690,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82320108010"],"award-info":[{"award-number":["82320108010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271816"],"award-info":[{"award-number":["82271816"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2024CXJQ01"],"award-info":[{"award-number":["2024CXJQ01"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202440161"],"award-info":[{"award-number":["202440161"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Insight"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cellin.2026.100327","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:20:38Z","timestamp":1777044038000},"page":"100327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Challenges and opportunities: CAR-T cell therapy in autoimmune diseases"],"prefix":"10.1016","volume":"5","author":[{"given":"Ran","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellin.2026.100327_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00281-024-01034-5","article-title":"Current advancements in cellular immunotherapy for autoimmune disease","volume":"47","author":"Berry","year":"2025","journal-title":"Seminars in Immunopathology"},{"issue":"7","key":"10.1016\/j.cellin.2026.100327_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"2","key":"10.1016\/j.cellin.2026.100327_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41584-024-01201-w","article-title":"Antigen-specific immunotherapies for autoimmune disease","volume":"21","author":"Buckner","year":"2025","journal-title":"Nature Reviews Rheumatology"},{"issue":"8","key":"10.1016\/j.cellin.2026.100327_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103851","article-title":"Autoreactive B cells in autoimmune diseases: Mechanisms, functions and clinical implications","volume":"24","author":"Collet","year":"2025","journal-title":"Autoimmunity Reviews"},{"issue":"20","key":"10.1016\/j.cellin.2026.100327_bib5","article-title":"Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR\/Cas9 nuclease-engineered T cells","volume":"122","author":"Engel","year":"2025","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/j.cellin.2026.100327_bib6","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1038\/s41591-025-03937-8","article-title":"Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: A phase 1 trial","volume":"31","author":"Feng","year":"2025","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.cellin.2026.100327_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-026-01779-6","article-title":"BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: Extended follow-up of a phase 1 clinical trial","volume":"19","author":"Hong","year":"2026","journal-title":"Journal of Hematology & Oncology"},{"issue":"1","key":"10.1016\/j.cellin.2026.100327_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13045-025-01737-8","article-title":"Recent advances in universal chimeric antigen receptor T cell therapy","volume":"18","author":"Jiang","year":"2025","journal-title":"Journal of Hematology & Oncology"},{"issue":"7949","key":"10.1016\/j.cellin.2026.100327_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: Design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellin.2026.100327_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tips.2025.11.001","article-title":"Autologous, allogeneic, in vivo CAR for autoimmune diseases","volume":"47","author":"Li","year":"2026","journal-title":"Trends in Pharmacological Sciences"},{"issue":"8","key":"10.1016\/j.cellin.2026.100327_bib11","article-title":"Emerging trends in clinical allogeneic CAR cell therapy","volume":"6","author":"Li","year":"2025","journal-title":"M\u00e9dica Sur"},{"key":"10.1016\/j.cellin.2026.100327_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjag002","article-title":"Genetically-determined systemic lupus erythematosus requires persistent CAR-T therapy: Challenging the transient depletion paradigm","author":"Liu","year":"2026","journal-title":"Journal of Molecular Cell Biology"},{"issue":"8","key":"10.1016\/j.cellin.2026.100327_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj6251","article-title":"Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control","volume":"10","author":"Lu","year":"2024","journal-title":"Science Advances"},{"issue":"10","key":"10.1016\/j.cellin.2026.100327_bib14","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.cellin.2026.100327_bib15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41591-025-04185-6","article-title":"CD19 CAR-T cells for treatment-refractory autoimmune diseases: The phase 1\/2 CASTLE basket trial","volume":"32","author":"M\u00fcller","year":"2026","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/j.cellin.2026.100327_bib16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41587-022-01637-z","article-title":"Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells","volume":"41","author":"Oh","year":"2023","journal-title":"Nature Biotechnology"},{"issue":"6","key":"10.1016\/j.cellin.2026.100327_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41587-024-02339-4","article-title":"A CAR enhancer increases the activity and persistence of CAR T cells","volume":"43","author":"Rakhshandehroo","year":"2025","journal-title":"Nature Biotechnology"},{"issue":"6","key":"10.1016\/j.cellin.2026.100327_bib18","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/S2665-9913(24)00377-1","article-title":"CAR T-cell therapy in autoimmune diseases: Where are we and where are we going?","volume":"7","author":"Scherlinger","year":"2025","journal-title":"The Lancet Rheumatology"},{"issue":"10","key":"10.1016\/j.cellin.2026.100327_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100749","article-title":"Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission","volume":"6","author":"Wang","year":"2025","journal-title":"Med"},{"issue":"18","key":"10.1016\/j.cellin.2026.100327_bib20","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.cellin.2026.100327_bib21","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.cell.2025.05.038","article-title":"An iPSC-derived CD19\/BCMA CAR-NK therapy in a patient with systemic sclerosis","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cellin.2026.100327_bib22","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1038\/s41591-025-03899-x","article-title":"Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: A phase 1 trial","volume":"31","author":"Wang","year":"2025","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2026.100327_bib23","article-title":"CAR T-cell therapy in autoimmune diseases: A promising frontier on the horizon","volume":"16","author":"Wu","year":"2025","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2026.100327_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1461102","article-title":"CAR immunotherapy in autoimmune diseases: Promises and challenges","volume":"15","author":"Yu","year":"2024","journal-title":"Frontiers in Immunology"}],"container-title":["Cell Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892726000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892726000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:24:03Z","timestamp":1783074243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772892726000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2772892726000301"],"URL":"https:\/\/doi.org\/10.1016\/j.cellin.2026.100327","relation":{},"ISSN":["2772-8927"],"issn-type":[{"value":"2772-8927","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and opportunities: CAR-T cell therapy in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Cell Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellin.2026.100327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Wuhan University.","name":"copyright","label":"Copyright"}],"article-number":"100327"}}